Rebecca A Gillespie

Title: Innovations in Influenza Vaccines by Rebecca A Gillespie

Introduction

Rebecca A Gillespie is a prominent inventor based in Bethesda, MD (US). She has made significant contributions to the field of immunology, particularly in the development of nanoparticle-based vaccines for influenza viruses. Her innovative approach utilizes self-assembling proteins to create effective vaccines that can elicit an immune response against a broad range of influenza strains.

Latest Patents

Rebecca A Gillespie holds a patent for "Nanoparticle-based influenza virus vaccines and uses thereof." This patent describes nanoparticles that are designed to provoke an immune response against hemagglutinin (HA) proteins from various influenza viruses. The nanoparticles are composed of self-assembling proteins, with at least one protein linked to an immunogenic portion of an influenza HA protein. This design allows the immunogenic portion to be displayed on the surface of the nanoparticles, making them effective for vaccinating individuals against influenza virus.

Career Highlights

Throughout her career, Rebecca has worked with esteemed institutions such as the University of Washington and the National Institutes of Health, which is a component of the US Department of Health & Human Services. Her work has been pivotal in advancing the understanding and development of vaccines that can combat influenza effectively.

Collaborations

Rebecca has collaborated with notable colleagues in her field, including Masaru Kanekiyo and Barney S Graham. These partnerships have contributed to the success of her research and the development of innovative vaccine solutions.

Conclusion

Rebecca A Gillespie's work in nanoparticle-based influenza vaccines represents a significant advancement in immunology. Her innovative approach and dedication to research continue to impact the field positively.